
The CDC and FDA reported last Friday that two samples collected by FDA tested positive for Clostridium botulinum type A.
One is a ByHeart powdered infant formula closed product sample that matches a clinical isolate from an infant included in this outbreak according to whole genome sequencing analysis (WGS).
The second whole milk powder sample was








